AIM IMMUNOTECH INC. Cash and Cash Equivalents, Period Increase (Decrease)
AIM IMMUNOTECH INC. (AIM) reported Cash and Cash Equivalents, Period Increase (Decrease) of $2.10 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-15.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-15
- AIM IMMUNOTECH INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $2.10M, a 17.68% decline year-over-year.
- AIM IMMUNOTECH INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$3.76M, a 513.20% decline year-over-year.
- AIM IMMUNOTECH INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $487.00K.
- AIM IMMUNOTECH INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$389.00K, a 187.22% decline year-over-year.
- AIM IMMUNOTECH INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$1.11M.
- AIM IMMUNOTECH INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$996.00K, a 439.93% decline from fiscal 2016.
- AIM IMMUNOTECH INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $293.00K.
- AIM IMMUNOTECH INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$41.00K, a 103.03% decline from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-03-31 | $2.10M 10-Q · filed 2019-05-15 | -$1.66M derived: sum of 2 quarters · filed 2019-05-15 | -$1.17M derived: sum of 3 quarters · filed 2019-05-15 | -$1.56M derived: sum of 4 quarters · filed 2019-05-15 |
| 2018-12-31 | -$3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$3.27M derived: sum of 2 quarters · filed 2019-04-01 | -$3.66M derived: sum of 3 quarters · filed 2019-04-01 | -$1.11M 10-K · filed 2019-04-01 |
| 2018-09-30 | $487.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $98.00K derived: sum of 2 quarters · filed 2018-11-14 | $2.64M 10-Q · filed 2018-11-14 | $3.55M derived: sum of 4 quarters · filed 2019-05-15 |
| 2018-06-30 | -$389.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $2.16M 10-Q · filed 2018-08-14 | $3.06M derived: sum of 3 quarters · filed 2019-05-15 | $2.35M derived: sum of 4 quarters · filed 2019-05-15 |
| 2018-03-31 | $2.54M 10-Q · filed 2019-05-15 | $3.45M derived: sum of 2 quarters · filed 2019-05-15 | $2.73M derived: sum of 3 quarters · filed 2019-05-15 | $3.18M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $909.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $190.00K derived: sum of 2 quarters · filed 2019-04-01 | $636.00K derived: sum of 3 quarters · filed 2019-04-01 | -$996.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | -$719.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$273.00K derived: sum of 2 quarters · filed 2018-11-14 | -$1.91M 10-Q · filed 2018-11-14 | -$3.97M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $446.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$1.19M 10-Q · filed 2018-08-14 | -$3.25M derived: sum of 3 quarters · filed 2018-08-14 | -$316.00K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | -$1.63M 10-Q · filed 2018-05-15 | -$3.70M derived: sum of 2 quarters · filed 2018-05-15 | -$762.00K derived: sum of 3 quarters · filed 2018-05-15 | -$237.00K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $870.00K derived: sum of 2 quarters · filed 2018-03-30 | $1.40M derived: sum of 3 quarters · filed 2018-03-30 | $293.00K 10-K · filed 2018-03-30 |
| 2016-09-30 | $2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $3.46M derived: sum of 2 quarters · filed 2017-11-14 | $2.36M 10-Q · filed 2017-11-14 | $3.31M derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-06-30 | $525.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$577.00K 10-Q · filed 2017-08-14 | $377.00K derived: sum of 3 quarters · filed 2018-03-30 | -$304.00K derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-03-31 | -$1.10M 10-Q · filed 2017-05-15 | -$148.00K derived: sum of 2 quarters · filed 2018-03-30 | -$829.00K derived: sum of 3 quarters · filed 2018-03-30 | -$1.93M derived: sum of 4 quarters · filed 2018-03-30 |
| 2015-12-31 | $954.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $273.00K derived: sum of 2 quarters · filed 2018-03-30 | -$827.00K derived: sum of 3 quarters · filed 2018-03-30 | -$41.00K 10-K · filed 2018-03-30 |
| 2015-09-30 | -$681.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$1.78M derived: sum of 2 quarters · filed 2016-11-14 | -$995.00K 10-Q · filed 2016-11-14 | -$101.00K derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$314.00K 10-Q · filed 2016-08-15 | $580.00K derived: sum of 3 quarters · filed 2017-03-31 | -$775.00K derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-03-31 | $786.00K 10-Q · filed 2016-05-16 | $1.68M derived: sum of 2 quarters · filed 2017-03-31 | $325.00K derived: sum of 3 quarters · filed 2017-03-31 | -$1.16M derived: sum of 4 quarters · filed 2017-03-31 |
| 2014-12-31 | $894.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$461.00K derived: sum of 2 quarters · filed 2017-03-31 | -$1.95M derived: sum of 3 quarters · filed 2017-03-31 | $1.35M 10-K · filed 2017-03-31 |
| 2014-09-30 | -$1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$2.84M derived: sum of 2 quarters · filed 2015-11-16 | $459.00K 10-Q · filed 2015-11-16 | -$336.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | -$1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $1.81M 10-Q · filed 2015-08-12 | $1.02M derived: sum of 3 quarters · filed 2016-03-29 | $1.31M derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | $3.30M 10-Q · filed 2015-05-12 | $2.51M derived: sum of 2 quarters · filed 2016-03-29 | $2.80M derived: sum of 3 quarters · filed 2016-03-29 | $2.52M derived: sum of 4 quarters · filed 2016-03-29 |
| 2013-12-31 | -$795.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$503.00K derived: sum of 2 quarters · filed 2016-03-29 | -$785.00K derived: sum of 3 quarters · filed 2016-03-29 | -$1.41M 10-K · filed 2016-03-29 |
| 2013-09-30 | $292.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $10.00K derived: sum of 2 quarters · filed 2014-11-07 | -$614.00K 10-Q · filed 2014-11-07 | -$1.56M derived: sum of 4 quarters · filed 2015-03-19 |
| 2013-06-30 | -$282.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$906.00K 10-Q · filed 2014-08-08 | -$1.85M derived: sum of 3 quarters · filed 2015-03-19 | -$864.00K derived: sum of 4 quarters · filed 2015-03-19 |
| 2013-03-31 | -$624.00K 10-Q · filed 2014-05-09 | -$1.57M derived: sum of 2 quarters · filed 2015-03-19 | -$582.00K derived: sum of 3 quarters · filed 2015-03-19 | -$2.06M derived: sum of 4 quarters · filed 2015-03-19 |
| 2012-12-31 | -$946.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $42.00K derived: sum of 2 quarters · filed 2015-03-19 | -$1.44M derived: sum of 3 quarters · filed 2015-03-19 | -$891.00K 10-K · filed 2015-03-19 |
| 2012-09-30 | $988.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$492.00K derived: sum of 2 quarters · filed 2013-11-08 | $55.00K 10-Q · filed 2013-11-08 | -$864.00K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | -$1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$933.00K 10-Q · filed 2013-08-09 | -$1.85M derived: sum of 3 quarters · filed 2014-03-14 | $90.00K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $547.00K 10-Q · filed 2013-05-08 | -$372.00K derived: sum of 2 quarters · filed 2014-03-14 | $1.57M derived: sum of 3 quarters · filed 2014-03-14 | $1.40M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | -$919.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $1.02M derived: sum of 2 quarters · filed 2014-03-14 | $856.00K derived: sum of 3 quarters · filed 2014-03-14 | $183.00K 10-K · filed 2014-03-14 |
| 2011-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $1.77M derived: sum of 2 quarters · filed 2012-11-02 | $1.10M 10-Q · filed 2012-11-02 | $978.00K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$840.00K 10-Q · filed 2012-08-08 | -$964.00K derived: sum of 3 quarters · filed 2013-03-18 | -$3.25M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | -$673.00K 10-Q · filed 2012-05-07 | -$797.00K derived: sum of 2 quarters · filed 2013-03-18 | -$3.08M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$2.41M derived: sum of 2 quarters · filed 2013-03-18 | -$55.15M 10-K · filed 2013-03-18 | |
| 2010-09-30 | -$2.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | -$55.03M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$52.74M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $51.95M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |